StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)

Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%

AbbVie gross margin

Gross margin is gross profit as a percentage of revenue.

AbbVie's gross margin for the twelve months ending Jun 30, 2026 was 71.5%. For fiscal 2025 it was 70.2%, against 70.0% the year before. The highest annual figure on record is 80.3% in fiscal 2015.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202570.2%+0.2
FY2024Dec 31, 202470.0%+7.6
FY2023Dec 31, 202362.4%−7.6
FY2022Dec 31, 202270.0%+1.0
FY2021Dec 31, 202169.0%+2.5
FY2020Dec 31, 202066.4%−11.2
FY2019Dec 31, 201977.6%+1.2
FY2018Dec 31, 201876.4%+1.4
FY2017Dec 31, 201775.0%−2.2
FY2016Dec 31, 201677.3%−3.1
FY2015Dec 31, 201580.3%+2.5
FY2014Dec 31, 201477.8%+2.2
FY2013Dec 31, 201375.6%+0.1
FY2012Dec 31, 201275.5%+2.1
FY2011Dec 31, 201173.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202674.7%+2.9
Q1 FY2026Mar 31, 202671.9%+1.9
Q4 FY2025Dec 31, 202572.6%+1.7
Q3 FY2025Sep 30, 202566.4%−4.5
Q2 FY2025Jun 30, 202571.8%+0.9
Q1 FY2025Mar 31, 202570.0%+3.3
Q4 FY2024Dec 31, 202470.9%+10.8
Q3 FY2024Sep 30, 202470.9%+17.4
Q2 FY2024Jun 30, 202470.9%+1.5
Q1 FY2024Mar 31, 202466.7%−0.7
Q4 FY2023Dec 31, 202360.1%−12.3
Q3 FY2023Sep 30, 202353.4%−12.7
Q2 FY2023Jun 30, 202369.4%−2.0
Q1 FY2023Mar 31, 202367.4%−2.7
Q4 FY2022Dec 31, 202272.4%+1.4
Q3 FY2022Sep 30, 202266.1%−3.3
Q2 FY2022Jun 30, 202271.4%+3.8
Q1 FY2022Mar 31, 202270.1%+2.5
Q4 FY2021Dec 31, 202171.0%+4.8
Q3 FY2021Sep 30, 202169.4%+8.5
Q2 FY2021Jun 30, 202167.6%+3.2
Q1 FY2021Mar 31, 202167.6%−9.9
Q4 FY2020Dec 31, 202066.2%−10.8
Q3 FY2020Sep 30, 202060.9%−16.5
Q2 FY2020Jun 30, 202064.4%−13.6
Q1 FY2020Mar 31, 202077.5%−0.9
Q4 FY2019Dec 31, 201977.0%+1.3
Q3 FY2019Sep 30, 201977.4%−0.4
Q2 FY2019Jun 30, 201978.0%+1.3
Q1 FY2019Mar 31, 201978.4%+2.6
Q4 FY2018Dec 31, 201875.7%+5.1
Q3 FY2018Sep 30, 201877.7%+0.8
Q2 FY2018Jun 30, 201876.6%−1.3
Q1 FY2018Mar 31, 201875.7%+0.4
Q4 FY2017Dec 31, 201770.5%−6.6
Q3 FY2017Sep 30, 201776.9%+0.3
Q2 FY2017Jun 30, 201778.0%–
Q1 FY2017Mar 31, 201775.3%–
Q4 FY2016Dec 31, 201677.1%–
Q3 FY2016Sep 30, 201676.6%–

More AbbVie figures

See a number that looks wrong?